Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl

Cell Reports(2023)10.1016/j.celrep.2023.112049Source: DataRank Database

A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl is a research paper published in Cell Reports (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

nct pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.64)OA: goldTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Evi P. Vlachou ORCID,Hamidreza Hashemi,Monique van Straaten ORCID,Johan Zeelen ORCID,Yosip Kelemen ORCID

Live enrichment

PubMed:36719797 PMC:PMC10387133 OpenAlex:https://openalex.org/W4318498913

National Institutes of Health

Grant: 1R43DA052960-01

National Institutes of Health

Grant: R01AI097127

NIDA NIH HHS

Grant: R43 DA052960

University of Minnesota

Helmholtz Association

FWCI

2.64

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2211124723000608/pdf

publisherhttp://www.cell.com/article/S2211124723000608/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124723000608?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124723000608?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2023.112049

Fields of Study

Monoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approachesHIV Research and Treatment

MeSH Terms

Analgesics, OpioidAnimalsFentanylImmunotherapyTrypanosomaTrypanosoma brucei bruceiTrypanosomiasis, AfricanVariant Surface Glycoproteins, TrypanosomaMice

Keywords

ImmunogenAntibodyAntigenBiologyRNA interferenceSortaseCell biologyComputational biologyGlycoproteinImmunizationMonoclonal antibodyRNAVirologyImmunologyMolecular biologyGeneBiochemistryHumoral immunityFentanylTrypanosoma BruceiImmunological MemoryVariant Surface GlycoproteinOpioid OverdoseAntibody Repertoire AnalysisCp: Immunology

Sustainable Development Goals

SDG 0: Good health and well-being

A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl

FAIR Checklist

Authors (21)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)